Ultragenyx Pharmaceutical Securities Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Ultragenyx Pharmaceutical · Drug candidate in a Phase III trial · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Ultragenyx Pharmaceutical
- Product or service
- Drug candidate in a Phase III trial
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- DJS Law Group lead plaintiff and case participation inquiry
Participation information
Availability is based on each listed participation option and its deadline.
DJS Law Group lead plaintiff and case participation inquiry
Shareholders who purchased Ultragenyx shares during the class period from August 3, 2023 through December 26, 2025 and suffered a loss.
Contact DJS Law Group regarding possible lead plaintiff appointment or participation in the case.
- Type
- Law Firm Signup
- Status
- Deadline passed
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Ultragenyx Pharmaceutical Securities Class Action
Barchart.com ·